Furthermore, many researchers revealed that ARG1-expressing MDSCs induced in a tumor-bearing state were related to the tumorigenesis of colon cancers, and the blockade of this immunosuppressive function showed anti-tumor effects, indicating promising targets for the treatment of CRC patients [24–26]. The gene discussed is ARG1; the disease is neoplasm.